TP53 mutations as a biomarker for high-grade serous ovarian cancer: Are we there yet?

Derek B. Oien, Jeremy Chien

Research output: Contribution to journalEditorial

5 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)S264-S268
JournalTranslational Cancer Research
Volume5
DOIs
StatePublished - Jan 1 2016
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

TP53 mutations as a biomarker for high-grade serous ovarian cancer : Are we there yet? / Oien, Derek B.; Chien, Jeremy.

In: Translational Cancer Research, Vol. 5, 01.01.2016, p. S264-S268.

Research output: Contribution to journalEditorial

@article{9911a1b9240441788634b8d9be82f2b1,
title = "TP53 mutations as a biomarker for high-grade serous ovarian cancer: Are we there yet?",
author = "Oien, {Derek B.} and Jeremy Chien",
year = "2016",
month = "1",
day = "1",
doi = "10.21037/tcr.2016.07.45",
language = "English (US)",
volume = "5",
pages = "S264--S268",
journal = "Translational Cancer Research",
issn = "2218-676X",
publisher = "AME Publishing Company",

}

TY - JOUR

T1 - TP53 mutations as a biomarker for high-grade serous ovarian cancer

T2 - Are we there yet?

AU - Oien, Derek B.

AU - Chien, Jeremy

PY - 2016/1/1

Y1 - 2016/1/1

UR - http://www.scopus.com/inward/record.url?scp=84991794217&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991794217&partnerID=8YFLogxK

U2 - 10.21037/tcr.2016.07.45

DO - 10.21037/tcr.2016.07.45

M3 - Editorial

AN - SCOPUS:84991794217

VL - 5

SP - S264-S268

JO - Translational Cancer Research

JF - Translational Cancer Research

SN - 2218-676X

ER -